Witt, Andreas
Ordóñez, Anna
Martin, Andrés
Vitiello, Benedetto
Fegert, Jörg M.
Article History
Received: 24 April 2020
Accepted: 27 April 2020
First Online: 11 May 2020
Disclaimer
: These are the views of the authors and don’t necessarily represent the views of the NIH or the Federal Government.
: Not applicable.
: Not applicable.
: JMF has received research funding from the EU, DFG (German Research Foundation), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), BfArM (Federal Institute for Drugs and Medical Devices), German armed forces, several state ministries of social affairs, State Foundation Baden-Württemberg, Volkswagen Foundation, Pontifical Gregorian University, CJD, Caritas, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from DFG, AACAP, NIMH/NIH, EU, Pro Helvetia, Shire, several universities, professional associations, political foundations, and German federal and state ministries during the last 5 years. Every grant and every honorarium has to be declared to the law office of the University Hospital Ulm. Professor Fegert holds no stocks of pharmaceutical companies.BV has been consultant for Medice and Lundeck Pharmaceuticals, and for law firms Goodwin & Procter and Haynes & Boone. He holds no stocks of pharmaceutical companies.AW, AO and AM state that they have no competing interests.